Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Subepidermal moisture (SEM) and bioimpedance: a literature review of a novel method for early detection of pressure-induced tissue damage (pressure ulcers).

Moore Z, Patton D, Rhodes SL, O'Connor T.

Int Wound J. 2017 Apr;14(2):331-337. doi: 10.1111/iwj.12604. Epub 2016 Apr 29. Review.

PMID:
27126794
2.

Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene-Pesticide Interactions in a Case-Control Study of Parkinson's Disease, California (USA).

Paul KC, Sinsheimer JS, Rhodes SL, Cockburn M, Bronstein J, Ritz B.

Environ Health Perspect. 2016 May;124(5):570-7. doi: 10.1289/ehp.1408976. Epub 2015 Sep 18.

3.

Inter-operator and inter-device agreement and reliability of the SEM Scanner.

Clendenin M, Jaradeh K, Shamirian A, Rhodes SL.

J Tissue Viability. 2015 Feb;24(1):17-23. doi: 10.1016/j.jtv.2015.01.003. Epub 2015 Feb 3.

4.

APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, Revilla FJ, Devoto J, Hu SC, Cholerton BA, Wan JY, Montine TJ, Edwards KL, Zabetian CP.

JAMA Neurol. 2014 Nov;71(11):1405-12. doi: 10.1001/jamaneurol.2014.1455.

5.

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB.

Mov Disord. 2014 Sep;29(10):1258-64. doi: 10.1002/mds.25924. Epub 2014 Jul 29.

6.

Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.

Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM.

Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083. Erratum in: Neurology. 2014 Nov 11;83(20):1880.

7.

Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.

Roede JR, Uppal K, Park Y, Lee K, Tran V, Walker D, Strobel FH, Rhodes SL, Ritz B, Jones DP.

PLoS One. 2013 Oct 22;8(10):e77629. doi: 10.1371/journal.pone.0077629. eCollection 2013.

8.

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B.

Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019. Epub 2013 Oct 8.

9.

Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

Rhodes SL, Fitzmaurice AG, Cockburn M, Bronstein JM, Sinsheimer JS, Ritz B.

Environ Res. 2013 Oct;126:1-8. doi: 10.1016/j.envres.2013.08.001. Epub 2013 Aug 27.

10.

Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.

Lee PC, Rhodes SL, Sinsheimer JS, Bronstein J, Ritz B.

Environ Int. 2013 Jun;56:42-7. doi: 10.1016/j.envint.2013.03.004. Epub 2013 Apr 16.

11.

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.

Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):636-41. doi: 10.1073/pnas.1220399110. Epub 2012 Dec 24.

12.

Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.

Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim HM, Agarwal P, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, Gómez-Garre P, Mir P, Ritz B, Rhodes SL, Colcher A, Van Deerlin V, Chung KA, Quinn JF, Yearout D, Martinez E, Farin FM, Wan JY, Edwards KL, Zabetian CP.

Mov Disord. 2012 Dec;27(14):1822-5. doi: 10.1002/mds.25226. Epub 2012 Oct 31.

13.

α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Ritz B, Rhodes SL, Bordelon Y, Bronstein J.

PLoS One. 2012;7(5):e36199. doi: 10.1371/journal.pone.0036199. Epub 2012 May 15.

14.

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.

Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, Park Y, Wang L, Gao J, Vance JM, Kendler KS, Bacanu SA, Scott WK, Ritz B, Nutt J, Factor SA, Zabetian CP, Payami H.

PLoS Genet. 2011 Aug;7(8):e1002237. doi: 10.1371/journal.pgen.1002237. Epub 2011 Aug 18.

15.

Replication of GWAS associations for GAK and MAPT in Parkinson's disease.

Rhodes SL, Sinsheimer JS, Bordelon Y, Bronstein JM, Ritz B.

Ann Hum Genet. 2011 Mar;75(2):195-200. doi: 10.1111/j.1469-1809.2010.00616.x. Epub 2010 Nov 8.

16.

α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease.

Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, Ritz B.

Neuroepidemiology. 2010;35(3):191-5. doi: 10.1159/000315157. Epub 2010 Jul 24.

17.

L-type calcium channel blockers and Parkinson disease in Denmark.

Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S.

Ann Neurol. 2010 May;67(5):600-6. doi: 10.1002/ana.21937.

18.

After half a century of research on smoking and PD, where do we go now?

Ritz B, Rhodes SL.

Neurology. 2010 Mar 16;74(11):870-1. doi: 10.1212/WNL.0b013e3181d63aa8. Epub 2010 Mar 10. No abstract available.

PMID:
20220125
19.

Application of Bayesian classification with singular value decomposition method in genome-wide association studies.

Kwon S, Cui J, Rhodes SL, Tsiang D, Rotter JI, Guo X.

BMC Proc. 2009 Dec 15;3 Suppl 7:S9.

20.

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.

Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H; Virahep-C Study.

Antimicrob Agents Chemother. 2009 Feb;53(2):615-21. doi: 10.1128/AAC.00947-08. Epub 2008 Oct 13.

21.

Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Rhodes SL, Ritz B.

Neurobiol Dis. 2008 Nov;32(2):183-95. doi: 10.1016/j.nbd.2008.07.001. Epub 2008 Jul 11. Review.

22.

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, Howell C, Ramcharran D, Rosen HR, Taylor MW, Liang TJ, Yang H; Virahep-C Study Group.

J Hepatol. 2008 Aug;49(2):184-91. doi: 10.1016/j.jhep.2008.04.011. Epub 2008 May 20.

23.

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.

Rhodes SL, Erlich H, Im KA, Wang J, Li J, Bugawan T, Jeffers L, Tong X, Su X, Rosen HR, Yee LJ, Liang TJ, Yang H; Virahep-C Study Group.

Genes Immun. 2008 Jun;9(4):328-33. doi: 10.1038/gene.2008.21. Epub 2008 Apr 17.

24.

Evidence for improving palliative care at the end of life: a systematic review.

Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG.

Ann Intern Med. 2008 Jan 15;148(2):147-59. Review. Erratum in: Ann Intern Med. 2009 Nov 3;151(9):674.

PMID:
18195339
25.

A systematic review of measures of end-of-life care and its outcomes.

Mularski RA, Dy SM, Shugarman LR, Wilkinson AM, Lynn J, Shekelle PG, Morton SC, Sun VC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Lorenz KA.

Health Serv Res. 2007 Oct;42(5):1848-70. Review.

26.

A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.

Huang Y, Yang H, Borg BB, Su X, Rhodes SL, Yang K, Tong X, Tang G, Howell CD, Rosen HR, Thio CL, Thomas DL, Alter HJ, Sapp RK, Liang TJ.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):985-90. Epub 2007 Jan 10. Erratum in: Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4770.

27.

Methodological approaches for a systematic review of end-of-life care.

Lorenz KA, Lynn J, Morton SC, Dy SM, Shugarman LM, Wilkinson A, Mularski RA, Sun VC, Hughes RG, Rhodes SL, Maglione M, Hilton LK, Rolon C, Shekelle PG.

J Palliat Med. 2005;8 Suppl 1:S4-11. Review.

PMID:
16499467
28.

Correlation of Drug-Testing Results - Immunoassay versus Gas Chromatography-Mass Spectrometry.

Huang MH, Liu RH, Chen YL, Rhodes SL.

Forensic Sci Rev. 2006 Jan;18(1):9-41. Review.

PMID:
26247108
29.

Identifying potential health care innovations for the future elderly.

Shekelle PG, Ortiz E, Newberry SJ, Rich MW, Rhodes SL, Brook RH, Goldman DP.

Health Aff (Millwood). 2005;24 Suppl 2:W5R67-76. Review.

30.

Smoking-cessation interventions by type of provider: a meta-analysis.

Mojica WA, Suttorp MJ, Sherman SE, Morton SC, Roth EA, Maglione MA, Rhodes SL, Shekelle PG.

Am J Prev Med. 2004 Jun;26(5):391-401. Review.

PMID:
15165655
31.

Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.

Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.

JAMA. 2003 Mar 26;289(12):1537-45. Epub 2003 Mar 10.

PMID:
12672771
32.

Double heterozygosity for the codon beta 39 C-to-T nonsense mutation and a triplicate alpha-globin gene locus can cause "dominantly" inherited beta-thalassemia intermedia.

Rhodes SL, Plonczynski M, Harrell A, Li J, Safaya S, Files JC, Steinberg MH.

Am J Med Sci. 1999 May;317(5):341-5.

PMID:
10334122
33.

Comparative intracytoplasmic sperm injection (ICSI) in human and domestic species.

Catt JW, Rhodes SL.

Reprod Fertil Dev. 1995;7(2):161-6; discussion 167.

PMID:
7480834
34.

Fertility of superovulated ewes after intrauterine or oviducal insemination with low numbers of fresh or frozen-thawed spermatozoa.

Maxwell WM, Evans G, Rhodes SL, Hillard MA, Bindon BM.

Reprod Fertil Dev. 1993;5(1):57-63.

PMID:
8234894
35.

Acid rain and drinking water degradation.

Middleton P, Rhodes SL.

Environ Monit Assess. 1984 Mar;4(1):99-103. doi: 10.1007/BF01047625.

PMID:
24259150
36.

Psychoanalytic theory and family systems theory: a complementary view.

Rhodes SL.

Int J Group Psychother. 1981 Jan;31(1):25-42. No abstract available.

PMID:
7203741
37.

Short-term groups of latency-age children in a school setting.

Rhodes SL.

Int J Group Psychother. 1973 Apr;23(2):204-16. No abstract available.

PMID:
4701534

Supplemental Content

Loading ...
Support Center